Invention Grant
US08222273B2 Polymorphic form of a [1,2,4]triazole[4,3-A] pyridine derivative inflammatory diseases
有权
[1,2,4]三唑[4,3-A]吡啶衍生物炎症性疾病的多形态
![Polymorphic form of a [1,2,4]triazole[4,3-A] pyridine derivative inflammatory diseases](/docs/US/2012-07-17/US08222273B2/abs.jpg.600x600.jpg)
- Patent Title: Polymorphic form of a [1,2,4]triazole[4,3-A] pyridine derivative inflammatory diseases
- Patent Title (中): [1,2,4]三唑[4,3-A]吡啶衍生物炎症性疾病的多形态
-
Application No.: US12865889Application Date: 2009-01-28
-
Publication No.: US08222273B2Publication Date: 2012-07-17
- Inventor: Kenneth John Butcher
- Applicant: Kenneth John Butcher
- Applicant Address: GB Sandwich, Kent
- Assignee: Pfizer Limited
- Current Assignee: Pfizer Limited
- Current Assignee Address: GB Sandwich, Kent
- Agent A. David Joran; Mary J. Hosley
- International Application: PCT/IB2009/050351 WO 20090128
- International Announcement: WO2009/098612 WO 20090813
- Main IPC: A61K31/437
- IPC: A61K31/437 ; C07D471/07
![Polymorphic form of a [1,2,4]triazole[4,3-A] pyridine derivative inflammatory diseases](/abs-image/US/2012/07/17/US08222273B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to a polymorphic form B of Λ/-[3-tert-butyl-1-(3-chloro-4-hydroxyphenyl)-1H-pyrazol-5-yl]-N-{2-[(3-{2-[(2-hydroxyethyl)sulfanyl]phenyl}[1,2,4]triazolo[4,3-a]pyridin-6-yl)sulfanyl]benzyl}urea (I) as de-fined herein. This polymorph is useful in the treatment of various conditions, particularly in the treatment of inflammatory conditions such as chronic obstructive pulmonary disease.
Public/Granted literature
- US20110003848A1 Polymorphic Form Of A [1,2,4]Triazole[4,3-A] Pyridine Derivative For Treating Inflammatory Diseases Public/Granted day:2011-01-06
Information query
IPC分类:
